0001387131-18-001152.txt : 20180320
0001387131-18-001152.hdr.sgml : 20180320
20180320174225
ACCESSION NUMBER: 0001387131-18-001152
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180316
FILED AS OF DATE: 20180320
DATE AS OF CHANGE: 20180320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Braunstein Douglas L
CENTRAL INDEX KEY: 0001495110
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37406
FILM NUMBER: 18702782
MAIL ADDRESS:
STREET 1: HUDSON EXECUTIVE CAPITAL LP
STREET 2: 1185 AVENUE OF THE AMERICAS, 32ND FL
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Corindus Vascular Robotics, Inc.
CENTRAL INDEX KEY: 0001528557
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 300687898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 309 WAVERLEY OAKS ROAD
STREET 2: SUITE 105
CITY: WALTHAM
STATE: MA
ZIP: 02452
BUSINESS PHONE: 508-653-3335
MAIL ADDRESS:
STREET 1: 309 WAVERLEY OAKS ROAD
STREET 2: SUITE 105
CITY: WALTHAM
STATE: MA
ZIP: 02452
FORMER COMPANY:
FORMER CONFORMED NAME: Your Internet Defender, Inc
DATE OF NAME CHANGE: 20110824
3
1
braunstein-form3_031618.xml
OWNERSHIP DOCUMENT
X0206
3
2018-03-16
0
0001528557
Corindus Vascular Robotics, Inc.
CVRS
0001495110
Braunstein Douglas L
HUDSON EXECUTIVE CAPITAL LP
570 LEXINGTON AVENUE, 35TH FLOOR
NEW YORK
NY
10022
1
0
0
0
Common Stock
11336154
I
See footnote
Series A Preferred Stock
1.25
2018-03-16
Common Stock
10800000
I
See footnote
Warrant
1.40
2018-09-16
2028-03-16
Common Stock
4725000
I
See footnote
Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), as the investment advisor to certain affiliated investment funds, and HEC Management GP LLC, a Delaware limited liability company ("Management GP"), as the general partner of Hudson Executive, may be deemed to be the beneficial owners of the securities beneficially reported on this Form 3. By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the securities reported for purposes of Rule 16a-1(a). Mr. Braunstein disclaims any beneficial ownership of the securities reported, except to the extent of any pecuniary interest therein.
The preferred stock is perpetual and therefore has no expiration date.
/s/ Douglas L. Braunstein
2018-03-20